Perkins Capital Management’s iBio IBIO Stock Holding History

Perkins Capital Management’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-6	Closed	-$10K	–	136
2013 Q4	$10K	Sell	6 -30	-83%	-$54.6K	0.01%	134
2013 Q3	$77K	Sell	36 -15	-29%	-$35.9K	0.06%	118
2013 Q2	$106K	Buy	+51	New	+$117K	0.08%	112

Other funds holding IBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Perkins Capital Management's IBIO Position: Q1 2014 in Review

Perkins Capital Management sold out of iBio (IBIO) in Q1 2014, closing a stake of 6 shares — an estimated $10K sold.

Perkins Capital Management first reported a position in IBIO in Q2 2013 and held it in 3 quarters. The position peaked at $106K in Q2 2013. 10 funds tracked by Wall St. Rank hold IBIO as of Q1 2014.

Perkins Capital Management reported no remaining iBio position as of Q1 2014 after selling out during the quarter.
Perkins Capital Management sold 6 iBio shares in Q1 2014, an estimated $10K.
Perkins Capital Management first reported a position in iBio in Q2 2013 and held it in 3 quarters.
Perkins Capital Management's iBio position peaked at $106K in Q2 2013.
10 funds tracked by Wall St. Rank held iBio as of Q1 2014.

Based on Perkins Capital Management's 13F filing for Q1 2014, filed 7 May 2014.